Contact us

Support


Home > Investment tools > They choose Russia > Besins Healthcare SA

Besins Healthcare SA

European pharmaceutical company Besins Healthcare will invest about 500 million rubles in the construction of a pharmaceutical factory in the Yaroslavl region. The company will launch the production of a full cycle of Utrozhestan for the treatment of gynecological diseases in 2019. This was reported today by the Press Office of the Government of the region.

“It is planned to start construction in 2017 and production - in 2019. The new factory will produce a full cycle of Utrozhestan, which is included in the all-Russian list of vital medicines. The scope of investment in the project is 500 million rubles,” the Press Office added.

14 February 2017
TASS

Besins Healthcare SA will build a new drug manufacturing plant in Yaroslavl Region. The new facility will produce Utrogestan which is included in the Russia's Essential Drugs List. Project investment will account for RUB 500 mln, the launch of commercial production is scheduled for 2019.

29 November 2016
regnum.ru
Investor
7.7 mln
Yaroslavl region

Investor profile

Besins Healthcare SA

Belgium

Company's website: www.besins-healthcare.com

T: 66 2 105 7888

Private company

Contact: Mr. Antoine Besins, President, Chairman of the Board

Besins Healthcare is a European private pharmaceutical company manufacturing innivative original medicines for male and female health.

Subscribe to Newsletters

Email: